PATENT CLAIM ANALYSIS

Application Number: 16049230
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["544", "316000"]

Abstract:
The invention provides a compound of formula (Ia), and pharmaceutically acceptable salts thereof. The invention also provides use of the compounds or salts as modulators of Kv3.1 and/or Kv3.2, and in the treatment of diseases or disorders where a modulator of Kv3.1 and/or Kv3.2 is required, such as depression and mood disorders, hearing disorders, schizopherenea, substance abuse disorders, sleep disorders or epilepsy.

Claim (Index 33):
The method according to  claim 31 , wherein R 1  is C 1-4 alkyl, C 1-4  alkoxy, or halo-C 1-4  alkoxy; R 2  is H, cyano or alkyl; X is N, Y is N or CH, R 3  is C 1-4  alkyl, and R 4  is C 1-4  alkyl or H; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 104.0
- Percentile: 95.0
- Lexical Diversity: 1.65909
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15722623', '13515097', '15348091', '14226988', '15730559']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8345865504163043
- 35 USC 102 Novelty (BERT): 0.6845559301257576
- Combined Prediction Score: 0.8195834883872496
- Mean Citation Score: 618.1228779999999
- Max Citation Score: 759.17053
- Similarity Product: 666.1328159369909

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test